BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹362 Cr | ₹296 Cr | ₹227 Cr | ₹184 Cr | ₹116 Cr |
What is the latest Revenue of BETA DRUGS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹362 Cr |
| Mar2024 | ₹296 Cr |
| Mar2023 | ₹227 Cr |
| Mar2022 | ₹184 Cr |
| Mar2021 | ₹116 Cr |
How is Revenue of BETA DRUGS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹362 Cr | 22.54 | |
| Mar2024 | ₹296 Cr | 30.21 | |
| Mar2023 | ₹227 Cr | 23.54 | |
| Mar2022 | ₹184 Cr | 58.31 | |
| Mar2021 | ₹116 Cr | - | |
Compare Revenue of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,477.4 Cr | 0.1% | 3.5% | 29.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 0.1% |
3.5% |
29.7% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses